text_1: 将 PARP 抑制剂 用于 复发性 卵巢癌 的 单药 治疗 或 用于 患者 对 铂 类药物 产生 应答 后 的 维持 治疗 时 , 此类 药物 有效 10 - 18 .
  
text_2: poly ( adenosine diphosphate [ ADP ] -ribose ) polymerase ( PARP ) inhibitors have efficacy as single agents in the treatment of recurrent ovarian cancer and as maintenance therapy after patients have had a response to platinum @-@ based therapy.10 @-@ 18
  